EP4371421A1 - Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin - Google Patents

Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin Download PDF

Info

Publication number
EP4371421A1
EP4371421A1 EP22208343.8A EP22208343A EP4371421A1 EP 4371421 A1 EP4371421 A1 EP 4371421A1 EP 22208343 A EP22208343 A EP 22208343A EP 4371421 A1 EP4371421 A1 EP 4371421A1
Authority
EP
European Patent Office
Prior art keywords
nicotine
oral
pouches
product
pouch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22208343.8A
Other languages
English (en)
French (fr)
Inventor
Pier Paolo MONTICONE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JT International SA
Original Assignee
JT International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JT International SA filed Critical JT International SA
Priority to EP22208343.8A priority Critical patent/EP4371421A1/de
Priority to JP2023147829A priority patent/JP2024074244A/ja
Priority to US18/511,351 priority patent/US20240164436A1/en
Publication of EP4371421A1 publication Critical patent/EP4371421A1/de
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F23/00—Cases for tobacco, snuff, or chewing tobacco
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D43/00—Lids or covers for rigid or semi-rigid containers
    • B65D43/02—Removable lids or covers
    • B65D43/0202—Removable lids or covers without integral tamper element
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D43/00—Lids or covers for rigid or semi-rigid containers
    • B65D43/14—Non-removable lids or covers
    • B65D43/16—Non-removable lids or covers hinged for upward or downward movement
    • B65D43/163—Non-removable lids or covers hinged for upward or downward movement the container and the lid being made separately
    • B65D43/164—Non-removable lids or covers hinged for upward or downward movement the container and the lid being made separately and connected by interfitting hinge elements integrally with the container and the lid formed respectively
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2543/00—Lids or covers essentially for box-like containers
    • B65D2543/00009—Details of lids or covers for rigid or semi-rigid containers
    • B65D2543/00018—Overall construction of the lid
    • B65D2543/00064—Shape of the outer periphery
    • B65D2543/00074—Shape of the outer periphery curved
    • B65D2543/00092—Shape of the outer periphery curved circular

Definitions

  • the present disclosure generally relates to a nicotine product, and more particularly to a nicotine pouch product container, a method of consuming a nicotine pouch product, and nicotine pouches and an oral product comprised in the nicotine pouch product container.
  • the nicotine pouch products are configured for oral use and deliver substances such as flavors and/or active ingredients during use.
  • Such products may include tobacco or a product derived from tobacco, or may be tobacco-free alternatives.
  • Some of the conventional smokeless articles have a saliva permeable pouch housing a content.
  • US 2012/0073588 A1 relates to an oral tobacco product which allows users to take in tobacco components via saliva
  • WO 2010/147024 A1 relates to an oral tobacco product for users to absorb tobacco ingredients via saliva, and it also provides a container case for containing such smokeless articles.
  • WO 91/06288 A1 relates to a saliva-soluble stimulant unit, and discloses some possible ingredients included in smokeless articles; it also explains that, considering the absorption of the nicotine, the pH of the saliva during the consumption of the smokeless articles can be basic.
  • the feeling with respect to basicity of a product varies for each user. Some users can start feeling basicity arising when a pH of a smokeless article is at 9, and some others can start feeling a basicity when a pH of a smokeless article is above 9. For example, when the pH of a smokeless product is 9.5, the sensation in the user mouth associated to the consumption of such a smokeless product can range from a simple tickling for one user to an important discomfort in the oral cavity for another user. Conventionally, to treat oral discomfort associated to the consumption of a product having a medium to high basicity, water dilution is recommended. However, water is not always reachable and water dilution may not be very effective and can be very slow.
  • the present invention provides a nicotine pouch product container, which solves some of or all of the above problems.
  • a nicotine pouch product container comprising:
  • the high side of the pH distribution of the plurality of nicotine pouches comprises nicotine pouches having a pH ranging from 9 to 11, wherein the high side of the pH distribution of the plurality of nicotine pouches represent at most 35%, preferably at most 25%, more preferably at most 15%, more preferably at most 10%, more preferably at most 5%, even more preferably at most 10% and even more preferably at most 10% of the total pH distribution of the plurality of nicotine pouches.
  • the buffer component in the oral product is in an amount sufficient to reduce the increased pH of the oral cavity of the user to a pH ranging from 6 to 8, preferably 6.5 to 7.5, as a consequence of using a nicotine pouch having a pH ranging from 9 to 11.
  • the oral product is in a solid form, preferably a patch, a chewing-gum, a capsule or a crash-ball.
  • the oral product is easier for the user to consume.
  • the oral product is arranged separately from the nicotine pouches.
  • the oral product is not within the same container as the nicotine pouches. It thus avoids any chemical reaction between the oral products and the nicotine pouches. For example, it might avoid any moisture balance reaction between the oral products and the nicotine pouches that would cause a decrease of moisture content in the nicotine pouches and increase a moisture content in the oral products. A change in moisture content of the nicotine pouches and increase a moisture content in the oral products could decrease the user experience.
  • the oral product comprising the buffer component substantially does not comprise nicotine.
  • each of the plurality of nicotine pouches has an outer surface with a first indication and the oral product comprising the buffer component has an outer surface with a second indication, wherein the first indication is different from the second indication, and preferably, the first indication and the second indication comprises a color, a printed pattern, and/or an embossing pattern.
  • the nicotine pouch product container comprises a first chamber and a second chamber, wherein the plurality of nicotine pouches are arranged in the first chamber and the oral product comprising the buffer component is contained in the second chamber.
  • the oral product comprising the buffer component is arranged in the plurality of nicotine pouches.
  • the buffer component consists of or comprises an acidic component, a mix of different acid components, or a mix of acid and basic components, and the acidic component is preferably an organic acid, and more preferably citric acid.
  • the oral product comprising the acidic component comprises 2-10 wt.%, preferably 3-8 wt.%, even more preferably 4-6 wt.% citric acid.
  • the oral product would be effective for a rapid tissue neutralization and reduction of discomfort in comparison to water irrigation alone and without an increased tissue damage risk secondary to the exothermic nature of acid-base reactions.
  • the acid component is in powder and/or in liquid form.
  • the acid component in liquid form is comprised in a capsule or in a crash-ball.
  • the oral product comprising the buffer component comprises a flavoring agent.
  • a method of consuming a nicotine pouch product comprising a plurality of nicotine pouches and at least one oral product, comprising the steps of:
  • a container comprising pouch products configured for oral use.
  • the term "configured for oral use” as used herein means that the pouch products are provided in a form such that during use, saliva in the mouth of the user causes one or more of the components of the mixture (e.g. flavoring agents, sweeteners, buffer components and/or nicotine) to pass into the mouth of the user.
  • the pouch product is adapted to deliver releasable components to a user through mucous membranes in the user's mouth and, in some instances, said releasable component can be an active ingredient that can be absorbed through the mucous membranes in the mouth when the product is used.
  • an "active ingredient” refers to one or more substances belonging to any of the following categories: API (active pharmaceutical ingredient), food additives, natural medicaments, and naturally occurring substances that can have an effect on humans.
  • Example active ingredients include any ingredient known to impact one or more biological functions within the body, such as ingredients that furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or which affect the structure or any function of the body of humans (e.g., provide a stimulating action on the central nervous system, have an energizing effect, an antipyretic or analgesic action, or an otherwise useful effect on the body).
  • the active ingredient maybe of the type generally referred to as dietary supplements, nutraceuticals, "phytochemicals” or “functional foods”.
  • dietary supplements e.g., nutraceuticals, "phytochemicals” or “functional foods”.
  • Non-limiting examples of active ingredients include those falling in the categories of botanical ingredients, stimulants, amino acids, nicotine components, and/or pharmaceutical, nutraceutical, and medicinal ingredients (e.g., vitamins, such as A, B3, B6, B12, and C, and/or cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD)).
  • active ingredients include those falling in the categories of botanical ingredients, stimulants, amino acids, nicotine components, and/or pharmaceutical, nutraceutical, and medicinal ingredients (e.g., vitamins, such as A, B3, B6, B12, and C, and/or cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD)).
  • vitamins such as A, B3, B6, B12, and C
  • cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD)
  • nicotine is preferably meant as nicotine extracted from tobacco. While the nicotine may be provided in several different forms, e.g. as a complex with an ion exchange resin, as a salt, or as a free base, the nicotine is not provided in the form of tobacco or powdered tobacco.
  • any "weight percentage of a releasable component” refers to a percentage by weight of that releasable component relative to the total weight of the oral composition, not including the weight of the pouch material.
  • the term "pouch” is intended to mean a container typically formed by a web of a fibrous material enclosing a cavity.
  • the pouch is a pouch designed for administration of an active ingredient in the oral cavity, and thus it is adapted for oral use, it is non-toxic and not water-soluble.
  • the fibrous material may form a woven or non-woven web or fabric.
  • the pouch may for example be sealed by bonding two corresponding pieces of web or fabric to each other along their edges to form a cavity for the nicotine and the non-water-soluble composition.
  • the pouch is made saliva-permeable so as to allow saliva from the oral cavity to penetrate the pouch and enter the cavity, where the saliva can come into contact with the active ingredient, whereby said active ingredient is released from the oral pouch.
  • a nicotine pouch product container 1 comprises a plurality of nicotine pouches 3, at least one oral product 2 that is different from the nicotine pouches 3, and a container case 4.
  • the number of the oral products 2 shown in figure 1 is only schematic.
  • the number of the oral products 2 comprised in a container case 4 can be any number, preferable the number of oral products 2 ranges from 1 to 10.
  • the number of the oral products 2 comprised in a container case 4 is at most 10 oral products 2, more preferably at most 8 oral products 2, more preferably at most 6 oral products 2, more preferably at most 4 oral products 2, even more preferably at most 3 oral products 2, particularly at most 2 oral products 2, and most preferably only 1 oral products 2.
  • the number of the nicotine pouches 3 comprised in a container case 4 can be any number and preferably at least 10 nicotine pouches, more preferably at least 20 nicotine pouches, even more preferably at least 40 nicotine pouches, particularly at least 60 nicotine pouches, and most preferably at least 100 nicotine pouches.
  • the number of nicotine pouches 3 in the nicotine pouch product container 1 is ranging from 15 to 35, most preferably from 20 to 30, and even most preferably from 20 to 25.
  • the nicotine pouch product container 1 comprises 15 to 35 nicotine pouches 3 and 1 to 10 oral products 2, most preferably 20 to 25 nicotine pouches 3 and 1 to 10 oral products 2.
  • the nicotine pouches 3 comprise a pouch and a composition comprising nicotine enclosed in said pouch.
  • the pouch is formed from a sheet of saliva permeable fibrous material.
  • the saliva permeable fibrous material can be formed of a woven or non-woven web or fabric.
  • saliva permeable fibrous material is formed of a non-woven web or fabric.
  • the nicotine mixture contains free nicotine or nicotine particles or nicotine salts or a combination thereof as an active ingredient.
  • the nicotine can be used in combination with tobacco. In such a case the nicotine is mixed with tobacco particles, which are obtained by shredding or crushing tobacco materials, and measure 2 mm or less in particle diameter.
  • the nicotine pouches could also be any other oral nicotine products available on the market.
  • the nicotine product 3 is placed between the upper lip and gum of the user to deliver nicotine when the nicotine product is exposed to saliva in the oral cavity of the user. Exposure to saliva then causes nicotine to be released into the mouth of the user, and further can cause some of the substrate material therein to pass through, e.g., the saliva permeable fibrous material of the pouch and provide the user with flavor and satisfaction. After about 10 minutes to about 60 minutes, typically about 15 minutes to about 45 minutes, of use/enjoyment, substantial amounts of the releasable component and or the substrate material have been ingested by the human subject, and the unit maybe removed from the mouth of the human subject for disposal. The nicotine product 3 does not emit smoke in use. The user can thus use the nicotine product 3 anywhere.
  • the nicotine content in the nicotine pouches 3 is extracted from tobacco.
  • the nicotine content in the nicotine pouches 3 comprises or is made of tobacco, and preferably a substantially small amount of tobacco. More specifically, the tobacco content is preferably at most 5% weight by weight of the total nicotine composition, more preferably at most 4% weight by weight of the total nicotine composition, even more preferably at most 3% weight by weight of the total nicotine composition; and/or preferably at least 1% weight by weight of the total nicotine composition, and more preferably at least 2% weight by weight of the total nicotine composition.
  • the nicotine composition has a moisture content ranging from 1%-60% weight by weight of the total nicotine composition.
  • the moisture content is ranging from 25%-60% weight by weight of the total nicotine composition, preferably ranging from 35%-55% weight by weight of the total nicotine composition, more preferably ranging from 35%-50% weight by weight of the total nicotine composition, even more preferably ranging from 35%-45% weight by weight of the total nicotine composition.
  • the moisture content of the nicotine composition is ranging from 1%-35% weight by weight of the total nicotine composition, preferably ranging from 1%-25% weight by weight of the total nicotine composition, more preferably ranging from 1%-18% weight by weight of the total nicotine composition, even more preferably ranging from 1%-12% weight by weight of the total nicotine composition, even more preferably below 10% weight by weight of the total nicotine composition.
  • the nicotine composition of the present invention has a pH preferably ranging from 7.5 to 11.
  • the nicotine composition is desirably alkaline.
  • the term "alkaline” means that the nicotine composition has a pH above 8.0.
  • the nicotine composition can have a pH ranging from 7.5 to 11, preferably ranging from 8.0 to 11, most preferably ranging from 8.5 to 10, and even most preferably above 8.
  • Having an alkaline nicotine composition implies that during the manufacturing process an alkaline buffer solution is used to buffer the nicotine composition at said desired alkaline pH. More particularly, when the alkaline nicotine composition comprises a pre-defined moisture content, e.g. a moisture content above 25% weight by weight of the total nicotine composition, the homogeneity of the alkaline nicotine composition during the addition of the alkaline buffer solution is a key step to provide an homogenous batch that will be used for providing a plurality of nicotine pouches at a predetermined pH. In particular, the inventors observed that for one batch of manufacturing 100 nicotine pouches the pH distribution of said plurality of nicotine pouches follows a gaussian-like curve, also called a bell-shaped pH distribution curve.
  • a gaussian-like curve also called a bell-shaped pH distribution curve.
  • the inventors observed that in said batch of manufacturing 100 nicotine pouches at a predetermined alkaline pH, e.g. a predetermined pH around 8.5, the pH distribution is divided into a low, a middle and a high pH side of the pH distribution.
  • the middle part of the pH distribution corresponds to the middle gaussian-like curve and defines an area comprising a plurality of nicotine pouches having a pH ranging from 8.2 to 8.8, i.e. a plurality of nicotine pouches having the targeted pH of about 8.5.
  • the low pH side i.e. the low tail of gaussian-like curve
  • the high pH side of the pH distribution i.e.
  • the high tail of gaussian-like curve correspond respectively to the left and right sides of the middle part of gaussian-like curve of the pH distribution.
  • the area of the high tail of gaussian-like curve comprises a plurality of nicotine pouches having a pH above 8.8 and in particular ranging from 8.8 to 11. Such an area can comprises for example 25 nicotine pouches.
  • the area of the low tail of gaussian-like curve comprises a plurality of nicotine pouches having a pH below 8.2 and ranging from 7.5 to 8.2. Such an area can comprises for example 25 nicotine pouches.
  • 50% of the plurality of nicotine pouches have a pH ranging from 8.2 to 8.8, 25% of the plurality of nicotine pouches have ranging from 7.5 to 8.2, and 25% of the plurality of nicotine pouches have ranging from 8.8 to 11.
  • the user puts one nicotine pouch taken in the 25% of the plurality of nicotine pouches having a pH ranging from 8,8 to 11, the user might then start rather quickly feeling a tickling or a discomfort sensation in the mouth, due to the use of a high pH nicotine pouch. This can be explained by the acid/basic reaction between the components in the saliva/in the buccal mucosa that are typically at a pH ranging from 6.5-7.5 and the nicotine pouch having a pH ranging from 8.8 to 11.
  • the pH distribution of the nicotine pouches in a container (7.5-11) comprises a low and a high pH side of the pH distribution.
  • the nicotine pouches that pertain to the high side of the pH distribution represent at most 35%, more likely (preferably) at most 25%, even more likely (preferably) at most 20%, most likely (preferably) at most 15%, most likely (preferably) at most 10% and most likely (preferably) at most 5% of the total distribution of the plurality of nicotine pouches.
  • the nicotine pouches that pertain to the high side of the pH distribution represent at least 35%, more likely (preferably) at least 25%, even more likely (preferably) at least 20%, most likely (preferably) at least 15%, most likely (preferably) at least 10% and most likely (preferably) at least 5% of the total distribution of the plurality of nicotine pouches.
  • the plurality of nicotine pouches 3 contained in a container 1 has a pH distribution defined by a bell-shaped pH distribution curve, i.e. a gaussian-like pH distribution.
  • the bell-shaped pH distribution curve has a low pH tail of the distribution (marked with the dotted line) and a high pH tail of the distribution (marked in black), wherein C is the cutoff pH value used to target the high tail.
  • the targeted pH value (C) is at most the 75th percentile, preferably at most the 85th percentile, more preferably at most the 90th percentile, and most preferably at most the 95th percentile of the pH distribution.
  • the high tail of the pH distribution preferably the 75th percentile (i.e., 25% of the nicotine pouches 3 in a container 1), has a pH of more than 9, more specifically a pH of 9 to 11.
  • the high tail of the pH distribution preferably the 95th percentile (i.e., 5% of the nicotine pouches 3 in a container 1), has a pH of more than 9, more specifically a pH of 9 to 11.
  • the oral product is provided in the container 1 for buffering the alkaline of the nicotine pouch 3 in case of discomfort.
  • the oral product 2 also called the oral patch
  • the buffer component in the at least one oral product is used at a quantity sufficient to reduce the increased pH arising in the user's mouth as a consequence of using a nicotine pouch selected from the plurality of nicotine pouches having a pH on the high pH side of the pH distribution, i.e.
  • the reference cutoff value C in figure 3 for the high pH side of the basic nicotine pouches 3 is also the reference value for the acidity and quantity of the oral product against the selected nicotine pouch 3 and ready for relieving and treating the discomfort.
  • the acidity and quantity of the oral product 2 should be tuned to target the high tail of the pH distribution of nicotine pouches 3.
  • the sum quantity of the buffer component of the oral product 2 (i.e., the acidity and quantity of the oral product 2) provided in a container should be sufficient to reduce the increased pH arising in the oral cavity of a user as a consequence of using a nicotine pouch selected from the plurality of nicotine pouches having a pH on the high pH side of the pH distribution.
  • the container 1 should have an amount of the buffer component sufficient to reduce the increased pH of the oral cavity of the user to a pH ranging from 6 to 8, preferably 6.5 to 7.5, as a consequence of using a nicotine pouch of the high pH side.
  • alkaline chemical discomfort treated with acid specifically a 5% acetic acid
  • the buffer component comprises citric acid, and preferably citric acid powder (HOC(CO 2 H)(CH 2 CO 2 H) 2 ), which typically is used for pH correction in cakes.
  • the Milliard TM citric acid is an example of such citric acid powder.
  • the dominant use of citric acid is as a flavoring and preservative in food and beverages, especially soft drinks and candies.
  • the buffer component contains other acids that can be used in food, for example, acetic acid, malic acid, DL Lactic Acid (food grade), L(+) Lactic Acid (food grade), Phosphoric Acid, L(+) Tartaric acid, Fumaric acid, or a combination thereof.
  • the buffer component may also be in liquid form obtained by dissolving the buffer component in a solvent.
  • a solvent water, alcohol, glycerin, propylene glycol or the like may be used. It is preferably comprised in a capsule or in a crash-ball.
  • the oral product comprising the acidic component e.g., acetic acid or citric acid powder as mentioned above, comprises 2-10 wt.%, preferably 3-8 wt.%, and even more preferably 4-6 wt.% citric acid.
  • the buffer component may consist of one acidic component or acidic concentration, a mix of different acid components, or a mix of acid and basic/neutral components.
  • the ingredients could be similar to the ingredient used for Sour Gummy Bears TM (pH 3.0), Skittles TM (pH 2.5), Starburst TM (pH 2.4), Sour Skittles TM (pH 2.2), Wonka Fun Dip TM (pH 1.8), Warheads Sour Spray TM (pH 1.6) etc.
  • the ingredients could comprise sugar, corn Syrup, citric acid, hydrogenated palm kernel oil; less than 2% of: Tapioca Dextrin, natural and artificial flavors, modified corn starch, colors, sodium citrate, Carnauba Wax, or a combination thereof.
  • the ingredients could comprise water, sugar, citric acid, malic acid, glycerin, lactic acid, artificial flavors, potassium sorbate preservative, or a combination thereof.
  • the acidity of the oral product 2 has a sufficient amount of buffer component as mentioned above such that, once the user takes the oral product 2, it takes at most 1 min, preferably at most 45 seconds, more preferably at most 30 seconds, even more preferably at most 15 seconds, and most preferably at most 5 seconds to substantially relieve the discomfort in the mouth caused by alkaline agents and the pH to return to a physiologic level namely the pH range mentioned above.
  • the oral product 2 may have a similar configuration as the nicotine pouches 3, but without comprising any nicotine.
  • the oral product 2 may comprise a pouch and a buffer component mixture enclosed in the pouch.
  • the pouch is formed from a sheet of saliva permeable fibrous material similar to the nicotine pouches 3.
  • the saliva permeable fibrous material can be formed of a woven or non-woven web or fabric. In a preferred embodiment, saliva permeable fibrous material is formed of a non-woven web or fabric.
  • the oral product 2 comprises a pouch 21 and a buffer component mixture.
  • the pouch 21 is formed from a sheet of saliva permeable fibrous material, preferably a saliva permeable fibrous material formed of a woven or non-woven web or fabric, and more preferably a saliva permeable nonwoven fabric.
  • the buffer component mixture comprises the buffer component as a major ingredient.
  • the oral product may further comprise at least one of a filler, binder, humectant, gelling agent, emulsifier, moisture content, sweetener, and flavorants.
  • the filler could be cellulose
  • the humectant could be glycerin.
  • the outer wrapper of the oral product 2 is in the form of a rectangular sheet.
  • the pouch 21 wraps the buffer component in a packaging form called pillow wrapping.
  • Other types of wrapping such as the tubular-shaped twist wrapping type, may also be used.
  • Other forms, such as capsule or crash-ball, that can be used in the oral cavity may also be used to contain the buffer component mixture; chewing-gum or sugar containing the acid (buffer component) may also be used.
  • the radius on the corner could be about 2 mm, while the dimensions could be about 14 mm in length, 6 mm in width and 3 mm in height. This size together with a jelly/rubber texture would allow positioning the acid patch in the same position the nicotine pouch was placed.
  • the ingredients for such an embodiment are, for example: 38%wt. of gelatin powder, 35%wt. of water, 18%wt. of sugar, 8%wt. of citric acid, aromas, coloring.
  • the oral patch could be rigid and more compact, e.g., a cylinder about 11 mm long and with a diameter of about 7 mm with rounded corners having about 3 mm radius.
  • the ingredients for such an embodiment are, for example: 50%wt. of sugar, 30%wt. of water, 12%wt. of corn syrup, 8%wt. of citric acid, aromas, coloring.
  • the weight and volume of the oral product 2 is preferably lower than the nicotine pouch, preferably at least 0.3 g, more preferably at least 0.4 g, and most preferably at least 0.5 g; and preferably at most 1 g, and more preferably at most 0.8 g, and most preferably at most 0.6 g.
  • Water-repellent fluorine-based resin is a suitable water-repellent material.
  • AsahiGuard TM manufactured by Asahi Glass Co., Ltd. is an example of such water-repellent fluorine-based resin. It is commonly used to coat wrappers for food and other products containing oils and fats, such as confectionery, dairy products, cooked food, fast food and pet food, and thus safe when applied to the pouch 21 intended to be put in the mouth.
  • the water-repellent material to be used is not restricted to the fluorine-based resin; other materials having water-repellency, such as paraffin resin, silicon-based resin and epoxy resin, are also usable.
  • the water-repellent material may contain an additive such as calcium carbonate or titanium dioxide. Such an additive increases the whiteness of the water-repellent material. Other materials, such as wax, could be used as well as there are options which are food grade and do not melt at body temperature.
  • the front and rear faces, i.e., at least a part of the outer surface, of the pouch 21 are colored with a different color from the nicotine pouch 3 as an indication 23.
  • a printed pattern and/or an embossing pattern 23 is provided on the pouch of the oral product 2.
  • the round-shaped colored patterns 23 are arranged along a longitudinal axis of the pouch 21, in one of the two longitudinal zones defined by the longitudinal axis of the pouch on the front and/or rear faces of the pouch 21.
  • indication 23 such as a combination of letters or a combination of numerals maybe presented on the front and/or rear faces of the pouch 21, indicating that it is the oral product 2, not the nicotine pouch 3.
  • a different size arrangement between the nicotine pouch 3 and the oral product 2 may also be an indication 23.
  • the oral product could be half of the size or just half of the width of the nicotine product, such as 14 mm in length, 3 mm in width, and 3 mm in height.
  • such indication methods may also be applied to capsules, (effervescent) tabletsor crush ball forms.
  • a food flavoring may be deposited or applied to the oral product.
  • Menthol, mint, vanilla, apricot, tea, cacao, licorice and honey maybe used alone or in combination as the food flavoring.
  • the food flavoring is desirably neutral or acid if it is deposited or applied thereto.
  • the food flavor is used in powder form or in the form of a liquid obtained by dissolving the food flavor in a solvent.
  • the solvent water, alcohol, glycerin, propylene glycol or the like may be used.
  • the food flavor is preferably used together with a humectant such as glycerin, propylene glycol or the like.
  • the nicotine pouches 3 and the oral product 2 are kept in the container case 4.
  • the container case 4 comprises a case body 46 and a lid 410.
  • the case body 46 is in the form of a flat cylinder, and the skilled person would understand that the case body 46 may also be of any other shapes and sizes, as long as it has a volume to contain the tobacco products 3 and oral product 2 inside.
  • the cover 420 is joined by a hinge 418 with the lid 410 so as to be openable closed with the lid 410. In other embodiments, the cover 420 and the lid 410 may be connected by other means or can be separated completely when opened.
  • the lid 410 has about the same shape as the case body 46 and has an outside dimension equal to the outside dimension of the case body 46.
  • the cover 420 In the closed position, the cover 420 is flush with the lid 410 and can be turned upward on the hinge 418 to expose an inner space of the lid 410.
  • the user can separate the lid 410 from the container body 46 to expose the inner space of the container body 46, where the nicotine products 3 are contained.
  • the container case 4 can keep the nicotine products 3 and oral products 2 separated.
  • the container case 4 has a lid inner space, which is the upper chamber of the container case 4, and a container body inner space, which is the lower chamber, and the plurality of nicotine pouches 3 are arranged in the lower chamber, and the oral product comprising the buffer component is contained in the upper chamber.
  • the nicotine pouches 3 can be stacked and placed under the lid 410 and separated from the oral product 2 which is placed inside the inner space or the hollow of the lid 410.
  • the opening of the cover 420 With the opening of the cover 420, the hollow space of the lid 410 is exposed, so that the user can remove an oral product 2 from the lid 410 through the opening of the lid 410.
  • the oral product 2 can be more reachable when necessary.
  • the lid 410 does not have a cover and is formed as an integrated piece, and to open the container case 4 for the nicotine pouches 3 and/or the oral product 2, the user can simply open the lid 410.
  • Separation means that separate the oral product 2 and nicotine products 3 may be a division plate that is vertically arranged in the inner space and on the bottom surface of case body 46, so that both the nicotine pouches 3 and the oral product 2 can easily be reached at the same time by the user.
  • the skilled person would understand that any other kind of separation means can be arranged in the case body 46 so as to separate the oral product 2 and the nicotine pouches 3.
  • the nicotine pouches 3 and the oral product 2 are arranged in the same inner space, and the user can still differentiate the oral product 2 and the nicotine pouches 3 by the above-mentioned indication 23 on the oral product 2.
  • a user contacts the above-mentioned nicotine pouch and consequently starts to feel a discomfort sensation in the mouth (the pH of the user mouth increases), he can open the cover 420 or the lid 410 and put one oral product 2, or even multiple oral products 2, into his or her mouth. With an acid-basic reaction caused by the oral product 2, the discomfort sensation will be relieved and said discomfort is neutralized to a physiologic level namely the pH range mentioned above.
  • the container case (4) further comprises a cavity (not shown in figure 1 ) for used nicotine pouches and/or for oral product 2.
  • the oral product 2 with the buffer component may also be provided within the nicotine pouches 3, and preferably each nicotine pouches 3.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
EP22208343.8A 2022-11-18 2022-11-18 Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin Pending EP4371421A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP22208343.8A EP4371421A1 (de) 2022-11-18 2022-11-18 Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin
JP2023147829A JP2024074244A (ja) 2022-11-18 2023-09-12 ニコチンパウチ製品用容器、及びニコチンパウチ製品用容器内のニコチンパウチ製品の消費方法
US18/511,351 US20240164436A1 (en) 2022-11-18 2023-11-16 Nicotine Pouch Product Container, and a Method of Consuming Nicotine Pouch Products Therein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22208343.8A EP4371421A1 (de) 2022-11-18 2022-11-18 Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin

Publications (1)

Publication Number Publication Date
EP4371421A1 true EP4371421A1 (de) 2024-05-22

Family

ID=84360162

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22208343.8A Pending EP4371421A1 (de) 2022-11-18 2022-11-18 Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin

Country Status (3)

Country Link
US (1) US20240164436A1 (de)
EP (1) EP4371421A1 (de)
JP (1) JP2024074244A (de)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006288A1 (en) 1989-11-07 1991-05-16 Anders Dam A nicotine containing stimulant unit
US20100018540A1 (en) * 2008-07-28 2010-01-28 David James Doolittle Smokeless tobacco products and processes
WO2010147024A1 (ja) 2009-06-16 2010-12-23 日本たばこ産業株式会社 口腔用たばこ製品
US20120073588A1 (en) 2009-06-17 2012-03-29 Japan Tobacco Inc. Oral tobacco product
EP3861873A1 (de) * 2020-02-10 2021-08-11 Nerudia Limited Behälter für rauchlosen artikel
US20220295864A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Liquid oral composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006288A1 (en) 1989-11-07 1991-05-16 Anders Dam A nicotine containing stimulant unit
US20100018540A1 (en) * 2008-07-28 2010-01-28 David James Doolittle Smokeless tobacco products and processes
WO2010147024A1 (ja) 2009-06-16 2010-12-23 日本たばこ産業株式会社 口腔用たばこ製品
US20120085360A1 (en) * 2009-06-16 2012-04-12 Norio Kawata Oral tobacco product
US20120073588A1 (en) 2009-06-17 2012-03-29 Japan Tobacco Inc. Oral tobacco product
US20220295864A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Liquid oral composition
EP3861873A1 (de) * 2020-02-10 2021-08-11 Nerudia Limited Behälter für rauchlosen artikel

Also Published As

Publication number Publication date
US20240164436A1 (en) 2024-05-23
JP2024074244A (ja) 2024-05-30

Similar Documents

Publication Publication Date Title
US20200128870A1 (en) A flavoured moist oral pouched nicotine product comprising triglyceride
EP2552245B1 (de) Hemmung von sensorischer irritation während des konsums von nicht rauchbaren tabakprodukten
US11388923B2 (en) Inhibition of undesired sensory effects by the compound camphor
US20080166395A1 (en) Article for delivering substrates to the oral cavity
CN103549646B (zh) 含烟草超微粉末的口崩片型无烟烟草制品及其制备方法
CN102770138B (zh) 含有尼古丁的软凝胶锭剂
KR20110071008A (ko) 다중 부분 경구내 투여량 형태 및 그의 용도
EP4371421A1 (de) Nikotinbeutelproduktbehälter und verfahren zum konsumieren von nikotinierten beutelprodukten darin
JP2023022200A (ja) 相互接続された活性成分含有パウチ
CN107950740A (zh) 一种富含硒的烟草口香糖
US9198943B2 (en) Silene capensis for inhibiting cravings
KR102215922B1 (ko) 담배 대용품용 조성물
AU2005220086A1 (en) Method and device for releasing flavor and odor substances
WO2014133562A1 (en) Dry powdered comestibles and packaging therefor
US20130298920A1 (en) Smokeless tobacco analogue and method of use
WO2006004418A2 (en) Encapsulated tobacco smoke
US20130189391A1 (en) Dry Powdered Comestibles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR